← back to search

Marieke Nill

Friedrich-Alexander-Universität Erlangen-Nürnberg · DE
Area of research
Oncology · Immunology
Research interest
Research focused on Blocking (statistics) and Cancer research, with related work in Immunosurveillance, Cre recombinase, Metastasis. Notable publications include 'Blocking the angiopoietin-2–dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis', 'ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer', and 'TAT-CRE inhalation enables tumor induction corresponding to adenoviral Cre-recombinase in a lung cancer mouse model'.
h-index
citations
15
works
3
NIH funding
primary concept
email

Recent publications

ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer
Nature Communications 2025cited by 3position: middledoi
TAT-CRE inhalation enables tumor induction corresponding to adenoviral Cre-recombinase in a lung cancer mouse model
Communications Biology 2025cited by 1position: middledoi
Blocking the angiopoietin-2–dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis
JCI Insight 2024cited by 11position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hans Christian Reinhardt · Düsseldorf University Hospital3 papers (2024–2025)Roland T. Ullrich · Miles College3 papers (2024–2025)Lydia Meder · Miles College3 papers (2024–2025)Alexandra Florin · Novartis (Switzerland)2 papers (2024–2025)Florian Klein · Chirurgische Universitätsklinik Heidelberg2 papers (2024–2025)Johannes Brägelmann · Kliniken Essen-Mitte2 papers (2024–2025) · 2 papers (2024–2025) · 2 papers (2024–2025)Marie‐Lisa Eich · Humboldt-Universität zu Berlin2 papers (2024–2025) · 2 papers (2025–2025)Xinlei Zhao · Nanjing Tech University2 papers (2025–2025) · 2 papers (2024–2025) · 1 papers (2025–2025)Meryem S. Ercanoglu · University of Cologne1 papers (2024–2024) · 1 papers (2025–2025)Qian Yang · Nanjing Agricultural University1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2024–2024) · 1 papers (2025–2025) · 1 papers (2025–2025)